Overview

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

Status:
Terminated

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if 1 course of antibiotic treatment with telithromycin is superior to azithromycin in the treatment of lower respiratory tract infections (LRTIs), acute exacerbations of chronic bronchitis (AECBs) and community-acquired pneumonia (CAP) in the community setting.

Phase:

Phase 4

Details

Lead Sponsor:

Sanofi

Treatments:

Azithromycin
Telithromycin